Daily low-dose aspirin in cancer patients with central venous catheter: New role for an old drug
2008 G. Curigliano, A. Balduzzi, A. Goldhirsch, M. Colleoni
Breast cancer and autoimmunity: The key in immunologic network imbalance?
2011 E. Magni, G. Curigliano, M. Rescigno, M.G. Zampino, F. Nolè, A. Goldhirsch
A man who bled from his nose: A rare case of fatal myelophthisis as solitary manifestation of solid tumour
2003 S. Di Cosimo, G. Ferretti, G. Curigliano, M. Mandala, N. Silvestris, M. D'Aprile
Combined Virtual Plant Experience and P ID Reading as Learning Experience for Chemical Plants Safety and Emergency Procedures
2026 C. Pirola, G. Tondelli, A. Ferlin, N. Bernareggi, E. Fiori, I. Tornelli, F. Manenti
Developing a Risk Index for Pilot and Research-scale Process Operations
2026 P. Mocellin, N. Bernareggi, C. Pirola
Pre-Synthesized WO3 Nanosheets via New Modified Thermal Exfoliation as a Route to Decouple Crystallinity from Loading in Pt/WO3/Al2O3 Glycerol Hydrogenolysis Catalysts
2026 M. Fontana, G. Pipitone, N. Braidy, M. Longhi, C. Pirola, F. Bossola, I. Tornelli, F. Galli
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
2023 S. Loibl, H.A. Azim, T. Bachelot, P. Berveiller, A. Bosch, E. Cardonick, C. Denkert, M.J. Halaska, M. Hoeltzenbein, A.L.V. Johansson, C. Maggen, U.R. Markert, F. Peccatori, P. Poortmans, E. Saloustros, C. Saura, P. Schmid, E. Stamatakis, M. van den Heuvel-Eibrink, M. Van Gerwen, V. Vandecaveye, G. Pentheroudakis, G. Curigliano, F. Amant
Targeting HER3 for cancer treatment: a new horizon for an old target
2023 J. Uliano, C. Corvaja, G. Curigliano, P. Tarantino
The triple negative breast cancer drugs graveyard: a review of failed clinical trials 2017-2022
2022 B. Taurelli Salimbeni, C. Corvaja, C. Valenza, P. Zagami, G. Curigliano
Current controversies in the use of Oncotype DX in early breast cancer
2025 P.P.M. Berton Giachetti, A.C. Schianca, D. Trapani, A. Marra, A. Toss, C. Marchiò, M.V. Dieci, O.D. Gentilini, C. Criscitiello, K. Kalinsky, J.A. Sparano, G. Curigliano
EUSOMA quality indicators for non-metastatic breast cancer: An update
2024 I.T. Rubio, L. Marotti, L. Biganzoli, C. Aristei, A. Athanasiou, C. Campbell, F. Cardoso, M.J. Cardoso, C.E. Coles, M. Eicher, N. Harbeck, A. Karakatsanis, B.V. Offersen, R. Pijnappel, A. Ponti, P. Regitnig, D. Santini, F. Sardanelli, T. Spanic, Z. Varga, M.J.T.F.D. Vrancken Peeters, Y. Wengstrom, L. Wyld, G. Curigliano
Explainable soft-sensing of dissolved oxygen in a multi-station aquatic monitoring network using ensemble machine learning and neural networks
2026 M.A.A.M. Hridoy, M. Bodini, C. Bordin, K.M.A. Adnan, M.S. Rahman, A.I. Shawkat, P. Ditthakit, P. Schneider, A. Masood, M.A. Al Mamun, P. Pastorino, L. Goliatt
DESTINY-Breast03 trial: some questions remain – Authors' reply
2023 S.A. Hurvitz, G. Curigliano, A. Egorov, S. Ashfaque, J. Cortes
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
2024 S. Rusakiewicz, S. Tyekucheva, S. Tissot-Renaud, K. Chaba, M. Imbimbo, F. Benedetti, R. Kammler, J. Hornfeld, E. Munzone, L. Gianni, B. Thurlimann, I. Lang, G. Pruneri, K.P. Gray, M.R. Regan, S. Loi, M. Colleoni, G. Viale, L. Kandalaft, G. Coukos, G. Curigliano
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations
2024 I. Meattini, C. Becherini, S. Caini, C.E. Coles, J. Cortes, G. Curigliano, E. De Azambuja, C.M. Isacke, N. Harbeck, O. Kaidar-Person, E. Marangoni, B.V. Offersen, H.S. Rugo, V. Salvestrini, L. Visani, A. Morandi, M. Lambertini, P. Poortmans, L. Livi, S. Alkner, I.S. Bhattacharya, L. Boersma, M. Callari, R.B. Clarke, L. Del Mastro, M. Ekholm, A. Gennari, A.M. Kirby, S. Kroeze, M. Malumbres, M. Vestmo Maraldo, G.N. Marta, I. Mjaaland, G. Morgan, B. Pistilli, S. Paluch-Shimon, S. Rivera, S. Rottenberg, C. Saura, T. Skytta, T. Spanic
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
2024 O. Kaidar-Person, I. Meattini, L.J. Boersma, C. Becherini, J. Cortes, G. Curigliano, E. De Azambuja, N. Harbeck, H.S. Rugo, L. Del Mastro, A. Gennari, C.M. Isacke, M. Vestmo Maraldo, E. Marangoni, G. Nader Marta, I. Mjaaland, V. Salvestrini, T. Spanic, L. Visani, A. Morandi, M. Lambertini, L. Livi, C.E. Coles, P. Poortmans, B.V. Offersen
Breast cancer: reimbursement policies and adoption of new therapeutic agents by National Health Systems
2019 D. Trapani, G. Curigliano, A. Eniu
Exploring the prognostic implications of programmed death-ligand 1 expression in canine nodal lymphoma: Insights from surface membrane expression, transcript amount and plasmatic levels
2026 A. Ubiali, L. Cesar Conti, R. De Maria, P.E.M. Dall'Ara, L. Marconato, R. Ferrari, D. Stefanello, M. Amati, L. Aresu, F. Riondato, V. Martini
Beyond Recipient Needs and Donor Self-Interests: Third-Kind Relational Drivers of Italy’s Aid Policy in Africa
2026 T. Corda, G. Carbone, C. Mella
Dalle teorie queer alla pedagogia queer: Una narrative review
2026 S. Colli Vignarelli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Article (author)216889
- Book Part (author)2
- Conference Object1
Data di pubblicazione
- 2020 - 202759505
- 2010 - 201982935
- 2000 - 200950657
- 1990 - 199916403
- 1980 - 19896299
- 1970 - 19791032
- 1960 - 196960
- 1959 - 19591
Editore
- Elsevier21458
- Springer10114
- MDPI6872
- Wiley5187
- Oxford University Press2912
- Wiley Blackwell Publishing2092
- Nature Publishing Group1742
- BioMed Central1676
- Taylor & Francis1615
- American Physical Society1490
Rivista
- PLOS ONE1283
- SCIENTIFIC REPORTS950
- EFSA JOURNAL895
- PHYSICAL REVIEW LETTERS884
- HAEMATOLOGICA847
- BLOOD825
- JOURNAL OF HIGH ENERGY PHYSICS816
- DIGESTIVE AND LIVER DISEASE710
- PHYSICS LETTERS. SECTION B667
- ANNALS OF ONCOLOGY665
Serie
- CEUR WORKSHOP PROCEEDINGS1
- METHODS IN MOLECULAR BIOLOGY1
- WORKING PAPERS1
Settore disciplinare
- Settore MED/09 - Medicina Interna8202
- Settore BIO/14 - Farmacologia7886
- Settore MED/26 - Neurologia4898
- Settore MED/18 - Chirurgia Generale4699
- Settore BIO/10 - Biochimica4623
- Settore MED/04 - Patologia Generale4484
- Settore MED/28 - Malattie Odontos...4291
- Settore MED/11 - Malattie dell'Ap...4135
- Settore FIS/01 - Fisica Sperimentale3888
- Settore MED/38 - Pediatria Genera...3878
Keyword
- Humans7181
- Female3596
- Male3332
- Middle Aged2191
- Adult2134
- Italy1835
- Aged1826
- COVID-191590
- Animals1434
- humans1177
Lingua
- eng173486
- ita40427
- fre1310
- spa742
- ger437
- por153
- rus124
- pol39
- chi17
- jpn13
Accesso al fulltext
- no fulltext85264
- open66326
- reserved56222
- partially open8009
- internalNetwork628
- restricted317
- mixed71
- embargoed55
Progetto
- -3104
- INF-ACT122
- MUSA114
- ON Foods110
- DUSTBUSTER109
- SERICS98
- UNVEIL81
- DiscEvol77
- DECC23_00971
- DECC23_00766